You are logged on as Guest.
RegisterLoginShopping cart (Empty)
 United States

IκBα (human), (recombinant) (GST-tag)

 
BML-UW9970-0050 50 µg 167.00 USD
 

Product Specification

Source/Host:Produced in E. coli.
 
Application:1. NF-κB pathway studies, inhibition of NF-κB p50/p65, substrate for IκB kinase (IKK). 2.Investigation of IκBa phosphorylation/ubiquitinylation/SUMOylation. 3. Ubiquitin-proteasome mediated degradation studies. 4.GST pull down of IκBa interacting partners.
 
Long Term Storage:-80°C
 
Miscellaneous/General:IκBa inhibits activation of the NF-κB pathway activation by associating with the major NF-κB heterodimeric complex p50/p65 and preventing its translocation from the cytoplasm into the nucleus, where it acts a transcription factor for genes involved in inflammation, autoimmune response, cell proliferation, and apoptosis. Inhibition of NF-κB pathway activation by IκBa is controlled by its sequential serine-phosphorylation, ubiquitination and proteasomal degradation. This process itself can be inhibited by SUMOylation of IκBa, providing an additional regulatory step for the activation of the NF-κB pathway.
 
Background / Technical Information:Please click here for the comprehensive product datasheet.
 

Product Toolbox

PRODUCT RESOURCES

Datasheet 
MSDS 

RELATED PRODUCTS

By catalog section:
By biological activity:
IkappaB Recombinant protein

PRODUCT SUPPORT

Technical Service
Bulk Quantity Quote
Customer Service

Related Literature

Catalogs
Ubiquitin & UBL Signaling Catalog
Add to order list
Ubiquitin & UBL Signaling Catalog 02-Oct-09
Download as PDF

All new literature pieces

©2010 Enzo Life Sciences, Inc.,